- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
DTA and Healthware Partner to Build European Coalition for Digital Therapeutics
The Digital Therapeutics Alliance (DTA) and Healthware will partner to form a coalition convening stakeholders from across the European region to discuss and develop pathways for the recognition of digital therapeutics at the global level. The first in-person meeting of the coalition will take place at Frontiers Health Global in October in Milan, Italy. The coalition will focus on co-creating a vision for the future by analyzing existing frameworks and infrastructure to build an environment to ensure safe and effective DTx therapies to be accessible to patients anywhere.The partnership between Healthware and DTA will develop resources to advance digital therapeutics to transform global healthcare through education, advocacy, and cross-industry collaboration.
Read more about this news release here.
